Susceptible bacteria are bacteria that can be stopped or killed by an antibiotic at normal doses. When a lab report labels a bacterial strain as “susceptible” to a particular drug, it means that drug is likely to work against the infection. This is the opposite of resistant bacteria, which survive despite antibiotic treatment.
How Susceptibility Is Defined
Susceptibility comes down to concentration. Every antibiotic needs to reach a certain level in your body to stop a particular type of bacteria from growing. That threshold is called the minimum inhibitory concentration, or MIC: the lowest amount of drug that prevents the bacteria from multiplying. If the MIC for a given bacterium falls within a range that standard doses of the antibiotic can easily achieve in your bloodstream, that bacterium is considered susceptible.
International standards bodies set specific cutoff points, called breakpoints, for each antibiotic-bacteria combination. These breakpoints divide bacteria into categories:
- Susceptible (S): Standard doses of the antibiotic will likely clear the infection.
- Susceptible, increased exposure (I): The antibiotic can still work, but only at higher doses or when it naturally concentrates at the infection site (like a urinary tract infection, where certain drugs accumulate in urine).
- Resistant (R): The antibiotic is unlikely to work regardless of dose.
So there are actually two categories of “treatable” and only one category of “not treatable.” The older term “intermediate” has been replaced with “susceptible, increased exposure” to make it clearer that these infections can still respond to the right dosing strategy.
How Susceptibility Is Tested
When you have a bacterial infection, your doctor may order a culture and susceptibility test. The lab grows bacteria from your sample (blood, urine, wound swab) and then exposes them to a panel of antibiotics. There are two main approaches.
In the dilution method, the lab mixes the bacteria into liquid or solid growth medium containing progressively lower concentrations of an antibiotic. The lowest concentration that stops visible bacterial growth is the MIC. This technique dates back to the 1940s and remains the gold standard.
In the disk diffusion method, small paper disks soaked in different antibiotics are placed on a plate covered with bacteria. The antibiotic seeps outward from each disk. If the bacteria are susceptible, a clear zone forms around the disk where nothing grows. The wider the zone, the more susceptible the bacteria are to that drug. If there’s no clear zone, the bacteria are resistant.
These tests typically take 18 to 24 hours after the bacteria have been grown in culture, which itself can take another day or two. That lag time is why doctors often start patients on a broad-spectrum antibiotic before results come back, then switch to a more targeted drug once the susceptibility report is available.
Why Susceptibility Matters for Treatment
The susceptibility report is the main tool doctors use to pick the right antibiotic for your infection. Labs generally recommend reporting results for narrow-spectrum antibiotics first, the drugs that target a smaller range of bacteria. This is deliberate: using the narrowest effective antibiotic reduces the chance of driving resistance in other bacteria living harmlessly in your body.
Broad-spectrum antibiotics like carbapenems and fluoroquinolones are held in reserve. Labs may perform susceptibility testing for these drugs but only report the results to the physician when narrower options won’t work. This practice, called selective reporting, is a key part of antibiotic stewardship, the effort to preserve the effectiveness of the antibiotics we have.
Susceptible in the Lab vs. in Your Body
A bacterium labeled “susceptible” on a lab report doesn’t guarantee the antibiotic will cure your infection. Lab testing happens under controlled conditions: ideal temperature, neutral pH, a standardized number of bacteria. Your body is far messier.
Several real-world factors can reduce an antibiotic’s effectiveness even against susceptible bacteria. An abscess, for example, creates a walled-off environment with acidic pH, low oxygen, and proteins that can bind to the drug and neutralize it. The fibrous capsule around an abscess also physically blocks the antibiotic from penetrating at high enough concentrations. Bacteria that form protective coatings (biofilms) on surfaces like heart valves or joint implants create a similar problem: the drug works fine in a test tube but can’t reach the bacteria hiding inside the biofilm.
This is one reason infections sometimes require more than antibiotics alone. Abscesses often need to be drained surgically, and infected implants may need to be removed, because the antibiotic simply cannot reach effective concentrations at the site no matter how susceptible the bacteria are in theory.
Susceptibility vs. Resistance vs. Persistence
These three terms describe very different situations, and they’re worth distinguishing. A susceptible bacterium lacks defenses against a given antibiotic and will be killed or stopped from growing at normal drug concentrations. A resistant bacterium carries genetic changes that allow it to survive the drug, and it passes that resistance to every daughter cell when it divides.
Persistence is a third, less well-known category. Persister cells are genetically susceptible to the antibiotic but enter a dormant state, essentially hibernating so the drug can’t affect them. They don’t carry resistance genes. Once the antibiotic course ends and these cells “wake up,” they resume growing and are once again susceptible to the same drug. Persistence helps explain why some infections relapse after what seemed like successful treatment.
How Bacteria Lose Their Susceptibility
Bacteria can shift from susceptible to resistant through several routes. Spontaneous mutations during DNA replication can alter the target site the antibiotic attacks, making the drug unable to bind. Bacteria can also acquire resistance genes from other bacteria through direct contact, a process that can spread resistance rapidly through a bacterial population.
Once a bacterium gains resistance, every cell it produces inherits that trait. This is why incomplete antibiotic courses and widespread antibiotic overuse are so concerning. Each exposure gives resistant mutants a survival advantage: the susceptible bacteria die off, leaving resistant ones with less competition for resources. Over time, what was once a fully susceptible species can become broadly resistant, limiting treatment options for everyone.
What a Susceptibility Report Looks Like
If you’ve had a culture done, you may receive a report listing the bacteria identified and a column of antibiotics, each marked S, I, or R. An “S” next to an antibiotic means the infection should respond to standard doses. An “I” means it could work with dose adjustments. An “R” means that antibiotic is off the table.
Your doctor uses this grid to select the most targeted, effective option. In some cases, multiple antibiotics show susceptibility, giving your doctor flexibility to choose based on side effects, how the drug is taken (oral vs. IV), cost, and how well it penetrates the specific tissue where your infection lives. In more concerning cases, only one or two options remain, a situation that’s becoming more common with the rise of multidrug-resistant organisms.